Top Buy
Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
Avid Bioservices Inc | 2 | 0 | 1 | 0 | €7.15 | €8.75 | 22.378% |
Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €62.00 | €66.53 | 7.305% |
Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €70.66 | €100.00 | 41.523% |
Bastide Le Confort | 1 | 0 | 1 | 0 | €18.02 | - | - |
Bausch Health Companies Inc. | 3 | 0 | 1 | 0 | €8.42 | €16.47 | 95.610% |
Baxter International | 3 | 0 | 0 | 0 | €37.93 | €48.16 | 26.973% |
Bayer AG | 15 | 1 | 0 | 0 | €28.60 | €50.00 | 74.825% |
Becton, Dickinson & Co. | 8 | 0 | 0 | 0 | €218.90 | €262.02 | 19.700% |
BeiGene Ltd ADR | 8 | 1 | 1 | 0 | €145.00 | €255.89 | 76.476% |
Biocryst Pharmaceuticals | 8 | 0 | 1 | 0 | €3.98 | €10.96 | 175.406% |
Biogen Inc. | 44 | 2 | 4 | 1 | €201.30 | €293.57 | 45.838% |
BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €77.98 | €102.62 | 31.597% |
Bio-Techne Corp. | 8 | 0 | 0 | 0 | €60.50 | €75.80 | 25.289% |
Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €87.72 | - | - |
Boston Scientific | 46 | 0 | 13 | 0 | €67.50 | €72.96 | 8.084% |
Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
Brookdale Sr Lvg | 2 | 0 | 1 | 0 | €6.40 | €8.27 | 29.263% |
Bruker Corp. | 7 | 1 | 0 | 1 | €73.08 | €85.68 | 17.247% |
Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.67 | €4.63 | 594.048% |
Catalent Inc. | 2 | 0 | 0 | 0 | €52.32 | €55.00 | 5.122% |
Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.36 | €23.46 | 63.398% |
Celldex Therapeutics | 9 | 1 | 0 | 0 | €35.20 | €51.20 | 45.447% |